Question: what phase clinical trial new drug application?
Would "A full series of trials may incur sizable costs, and the burden of paying for all the necessary people and services is usually borne by the sponsor, which may be a governmental organization or a pharmaceutical , biotechnology or medical device company." be a reasonable answer? 